A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A

Vincent Muczynski (1) , Sebastien Verhenne (2) , Caterina Casari (2) , Ghislaine Chérel , Laurence Panicot-Dubois (3, 4) , Paul Gueguen (5) , Marc Trossaërt (6) , Christophe Dubois (3, 4) , Peter J. Lenting (2) , Cecile V Denis (2) , Olivier D Christophe (2)

1 SCSR (U_967) - Stabilité génétique, cellules souches et radiations
2 HITH - U1176 Inserm - CHU Bicêtre - Hémostase, Inflammation, Thrombose
3 VRCM - Vascular research center of Marseille
4 C2VN - Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research
5 Génétique moléculaire et génétique épidémiologique
6 Centre Régional de traitement de l’hémophilie [CHU Nantes]

Domains: Life Sciences [q-bio]

Vincent Muczynski, Sebastien Verhenne, Caterina Casari, Ghislaine Chérel, Laurence Panicot-Dubois, et al.. A Thrombin-Activatable Factor X Variant Corrects Hemostasis in a Mouse Model for Hemophilia A. Thrombosis and Haemostasis, 2019, 119 (12), pp.1981-1993. ⟨10.1055/s-0039-1697662⟩. ⟨hal-02570572⟩